Stratos Genomics Raises Additional $2.1M in Series A Funding

Stratos Genomics Inc., a Seattle, WA-based developer of a single-molecule detection process, has raised an additional $2.1m in Series A funding.

Investors include existing shareholders Fisk Ventures and Stratos Group LLC (from which the company spun out in 2007).

Stratos intends to use the funds, which add to August 2010’s $4m financing (read the news), to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics.

Led by CEO Allan Stephan, the company develops a single-molecule detection process that allows accurate, ultra-low-cost whole genome sequencing (Sequencing by Expansion™” – SBX™).



Join the discussion